📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Commentary on Roberts et al. (2016): Bupropion and varenicline are efficacious and well-tolerated cessation medications for smokers with serious mental illness. (2016)

First Author: Prochaska JJ

Attributed to: The UK Centre for Tobacco and Alcohol Studies (UKCTAS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/add.13293

PubMed Identifier: 26995173

Publication URI: http://europepmc.org/abstract/MED/26995173

Type: Journal Article/Review

Volume: 111

Parent Publication: Addiction (Abingdon, England)

Issue: 4

ISSN: 0965-2140